These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 3561422

  • 1. [Various characteristics of the structure and synthesis of procollagens produced by cultured skin fibroblasts from patients with Danlos-Ehlers syndrome type I].
    Sokolov BP, Sher BM, Lomova TIu, Kukharenko VI, Blinnikova OE.
    Mol Gen Mikrobiol Virusol; 1987 Jan; (1):19-23. PubMed ID: 3561422
    [Abstract] [Full Text] [Related]

  • 2. Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts.
    Byers PH, Holbrook KA, Barsh GS, Smith LT, Bornstein P.
    Lab Invest; 1981 Apr; 44(4):336-41. PubMed ID: 6259441
    [Abstract] [Full Text] [Related]

  • 3. [Synthesis of procollagen proteins in cultured skin fibroblasts of patients with Ehlers-Danlos type I syndrome from a subisolated Azerbaijan population].
    Lomova TIu, Sher BM, Shakhova IK, Del'vig AA, Kukharenko VI.
    Mol Gen Mikrobiol Virusol; 1986 Feb; (2):35-9. PubMed ID: 2946946
    [No Abstract] [Full Text] [Related]

  • 4. Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen.
    Pyeritz RE, Stolle CA, Parfrey NA, Myers JC.
    Am J Med Genet; 1984 Nov; 19(3):607-22. PubMed ID: 6507506
    [Abstract] [Full Text] [Related]

  • 5. The mRNA and the activity of lysyl hydroxylase are up-regulated by the administration of ascorbate and hydralazine to human skin fibroblasts from a patient with Ehlers-Danlos syndrome type VI.
    Yeowell HN, Walker LC, Marshall MK, Murad S, Pinnell SR.
    Arch Biochem Biophys; 1995 Aug 20; 321(2):510-6. PubMed ID: 7646078
    [Abstract] [Full Text] [Related]

  • 6. Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen.
    Utani A, Tanaka T, Nishigori C, Miyachi Y, Danno K, Imamura S, Hosokawa M, Takeda T, Hirayoshi K, Nagata K.
    Lab Invest; 1990 Aug 20; 63(2):181-8. PubMed ID: 2199725
    [Abstract] [Full Text] [Related]

  • 7. Enzyme-linked immunoassay and electrophoretic separation of collagens secreted by cultured skin fibroblasts of patients with Ehlers-Danlos and Marfan syndromes.
    Borisova NV, Safronova EE, Krasnopol'skaya KD, Blinnikova OE, Polyudov SA.
    Biomed Sci; 1991 Aug 20; 2(5):523-9. PubMed ID: 1840842
    [Abstract] [Full Text] [Related]

  • 8. Single-strand conformation polymorphism (SSCP) analysis of the COL3A1 gene detects a mutation that results in the substitution of glycine 1009 to valine and causes severe Ehlers-Danlos syndrome type IV.
    Nuytinck L, De Paepe A, Renard JP, Adriaens F, Leroy J.
    Hum Mutat; 1994 Aug 20; 3(3):268-74. PubMed ID: 8019562
    [Abstract] [Full Text] [Related]

  • 9. [Structural characteristics of collagens from the skin and rib cartilage of patients with Ehlers-Danlos syndrome type II].
    Sokolov BP, Sher BM, Kozlov EA, Tsvetkova TA, Rudakov SS, Del'vig AA, Kalinin VN.
    Vopr Med Khim; 1990 Aug 20; 36(1):90-3. PubMed ID: 2343586
    [Abstract] [Full Text] [Related]

  • 10. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII.
    Ho KK, Kong RY, Kuffner T, Hsu LH, Ma L, Cheah KS.
    Hum Mutat; 1994 Aug 20; 3(4):358-64. PubMed ID: 8081389
    [Abstract] [Full Text] [Related]

  • 11. Low production of procollagen III by skin fibroblasts from patients with Ehlers-Danlos syndrome type IV is not caused by decreased levels of procollagen III mRNA.
    Aumailley M, Pöschl E, Martin GR, Yamada Y, Müller PK.
    Eur J Clin Invest; 1988 Apr 20; 18(2):207-12. PubMed ID: 3133227
    [Abstract] [Full Text] [Related]

  • 12. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI.
    Pasquali M, Still MJ, Vales T, Rosen RI, Evinger JD, Dembure PP, Longo N, Elsas LJ.
    Proc Assoc Am Physicians; 1997 Jan 20; 109(1):33-41. PubMed ID: 9010914
    [Abstract] [Full Text] [Related]

  • 13. Synthesis of an altered type III procollagen in a patient with type IV Ehlers-Danlos syndrome. A structural change in the alpha 1(III) chain which makes the protein more susceptible to proteinases.
    Stolle CA, Pyeritz RE, Myers JC, Prockop DJ.
    J Biol Chem; 1985 Feb 10; 260(3):1937-44. PubMed ID: 2981879
    [Abstract] [Full Text] [Related]

  • 14. Aberrant splicing of the type III procollagen mRNA leads to intracellular degradation of the protein in a patient with Ehlers-Danlos type IV.
    Thakker-Varia S, Anderson DW, Kuivaniemi H, Tromp G, Shin HG, van der Rest M, Glorieux FH, Ala-Kokko L, Stolle CA.
    Hum Mutat; 1995 Feb 10; 6(2):116-25. PubMed ID: 7581395
    [Abstract] [Full Text] [Related]

  • 15. Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture.
    Uitto J, Bauer EA, Eisen AZ.
    J Clin Invest; 1979 Oct 10; 64(4):921-30. PubMed ID: 90059
    [Abstract] [Full Text] [Related]

  • 16. Characterization of type II and type XI collagen synthesis by an immortalized rat chondrocyte cell line (IRC) having a low level of type II collagen mRNA expression.
    Oxford JT, Doege KJ, Horton WE, Morris NP.
    Exp Cell Res; 1994 Jul 10; 213(1):28-36. PubMed ID: 8020600
    [Abstract] [Full Text] [Related]

  • 17. [Vascular Ehlers-Danlos syndromes--biochemical and molecular-genetic investigations].
    Lund AM.
    Ugeskr Laeger; 2006 Feb 27; 168(9):915-20. PubMed ID: 16513057
    [Abstract] [Full Text] [Related]

  • 18. [Biochemical defects in hereditary diseases of the connective tissue (review)].
    Del'vig AA.
    Vopr Med Khim; 1986 Feb 27; 32(2):2-14. PubMed ID: 3518233
    [No Abstract] [Full Text] [Related]

  • 19. Collagen biosynthesis by human skin fibroblasts. II. Isolation and further characterization of type I and type III procollagens synthesized in culture.
    Uitto J, Booth BA, Polak KL.
    Biochim Biophys Acta; 1980 Aug 21; 624(2):545-61. PubMed ID: 7417491
    [Abstract] [Full Text] [Related]

  • 20. Procollagen synthesis and extracellular matrix deposition in MG-63 osteosarcoma cells.
    Jukkola A, Risteli L, Melkko J, Risteli J.
    J Bone Miner Res; 1993 Jun 21; 8(6):651-7. PubMed ID: 8328306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.